List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 261 studies with search of:   Open Studies | United States, Delaware
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: clodronate disodium;   Drug: ibandronate sodium;   Drug: zoledronic acid
2 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: placebo
3 Recruiting Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid;   Osteoarthritis
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
4 Recruiting Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Procedure: observation
5 Recruiting Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)
Condition: Carcinoma, Renal Cell
Interventions: Drug: Sunitinib Malate Continuous Daily Dosing;   Drug: Sunitinib Malate Schedule 4/2
6 Recruiting Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: cetuximab;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
7 Recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: letrozole;   Drug: placebo
8 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: bevacizumab;   Drug: cisplatin;   Drug: docetaxel;   Drug: fluorouracil
9 Recruiting Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Condition: Colorectal Cancer
Interventions: Drug: cetuximab;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
10 Recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: exemestane;   Drug: letrozole;   Drug: tamoxifen citrate;   Procedure: chemotherapy
11 Recruiting GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)
Condition: Osteoarthritis
Interventions: Drug: Celecoxib;   Drug: Any commercially available NSAID with the indication for osteoarthritis
12 Recruiting Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: exemestane;   Drug: tamoxifen citrate;   Drug: triptorelin;   Procedure: adjuvant therapy;   Procedure: oophorectomy;   Procedure: radiation therapy
13 Recruiting Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis
Conditions: Candidiasis;   Candida
Intervention: Drug: anidulafungin
14 Recruiting Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: placebo;   Drug: sorafenib tosylate;   Drug: sunitinib malate
15 Recruiting Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: letrozole;   Drug: placebo;   Drug: tamoxifen citrate
16 Recruiting Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: placebo;   Drug: zoledronic acid
17 Recruiting Assessment and Tracking of Long-Term Alefacept Safety
Condition: Psoriasis
Intervention: Drug: Alefacept exposure
18 Recruiting Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Drug: epratuzumab;   Drug: fludeoxyglucose F 18;   Drug: rituximab
19 Recruiting Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: bevacizumab;   Drug: sorafenib tosylate;   Drug: temsirolimus
20 Recruiting Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Intervention: Procedure: quality-of-life assessment

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services